NDC 50090-6089-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6089
- Requested NDC
- 50090-6089-01
- Package NDCs from labels
- 50090-6089-0, 50090-6089-1, 50090-6089-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2025-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6089-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 50090-6089-1 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6089 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230602_70d84fe0-afc4-4ef2-b4d8-f156abac3d1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6089-0 | EA - Each | 50090-6089 | 1b7b2683-840d-46d0-917e-a7d77279de70 | 1 | 2022-10-06 |
| 50090-6089-1 | EA - Each | 50090-6089 | bbb03dd6-2ec1-454d-b7e9-edf6bd5c9c2f | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magnesium Oxide | MAGNESIUM OXIDE | A-S Medication Solutions | c14d2b4d-d6d8-4293-835e-5d893d5b7e6a | 2025-10-10 | Warnings | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | bcf10012-8920-4737-92f5-7401ee0c5894 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 00a4fc0b-7162-455e-8ed3-56efdbbe182e | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | 966222 966270 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2aab0208-81ad-4607-8196-b4dc5ad5fdaa | 2025-09-05 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 194bc35b-ac82-4a40-bbd4-68eaff50b380 | 2025-09-05 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 37a55040-a9a2-4ff4-8463-9e1c7823d6ff | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 2e242b93-bc4f-405a-a194-1981c721ad94 | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 609352a9-740f-4874-997b-60b58d0c2b8a | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 9e588c43-b9b5-478e-99f7-e197add3cd26 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 892246 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | c1b0fbad-5816-4152-ab59-05079e8c2148 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 9e3bffb9-f66e-4c73-befc-e60d769f6610 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 64aaeba7-1013-44a4-96fc-b876016897b3 | 2025-07-25 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Mylan Institutional Inc. | cd69c192-cd3f-47e6-b0a6-c536ffed5c4b | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 966248 966270 966249 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | cfab474d-3272-41fd-a8ec-762dd1a84fa6 | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b9a50170-ac0b-483e-9e85-1d03b12e4f7d | 2025-07-23 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | REMEDYREPACK INC. | 0fa2e2f5-401b-45c1-b6a5-d02f6faf509d | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966248 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Mylan Institutional Inc. | 5723c7a7-2a1d-4ab6-bf39-b2165ae781a6 | 2025-07-22 | Boxed warning, Warnings, Adverse reactions | 966222 892246 966221 966224 966220 966225 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals, Inc. | 398a00d0-1247-4f6f-b4c1-dade399cc417 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70d84fe0-afc4-4ef2-b4d8-f156abac3d1f | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | ANDA212399 50090-6089-1 50090-6089-0 50090-6089 50090608901 966270 1b0cfab3-e4de-4018-9269-f84715643cf1 70d84fe0-afc4-4ef2-b4d8-f156abac3d1f 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | ff7f5eff-4c90-4aa0-8915-704f92dea8aa | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.